TheCorporateCounsel.net

August 1, 2023

Officer Exculpation: The 2023 Proxy Season Results Are In. . .

When Delaware amended Section 102(b)(7) of the DGCL last year to permit charter amendments exculpating officers from damages liability for breaches of the duty of care, people wondered whether many companies would propose amendments during the 2023 proxy season and, more importantly, how stockholders would react to those proposals. This excerpt from a Weil memo on this year’s officer exculpation proposals provides some answers to those questions:

Between August 1, 2022, when the amendment to DGCL Section 102(b)(7) became effective and July 5, 2023, 279 Delaware corporations included a proposal in their proxy statement requesting stockholder approval for a charter amendment to adopt an exculpatory provision for officers. Stockholders approved such proposal at 221 (79.2%) companies and did not approve the proposals at 42 of the 279 companies (15.1%). The results of the votes at 17 companies remain outstanding at the time of this publication.

Generally, pursuant to Section 242 of the DGCL, a charter amendment requires the vote of a majority of the outstanding stock entitled to vote on the matter. For companies that require supermajority approval under their governing documents, the higher vote threshold proved to be a hurdle to stockholder approval. Specifically, 18 of the 42 proposals that failed required a supermajority vote, 13 of which would have passed had the Delaware default standard applied.

People also wondered how the proxy advisors would react to these proposals.  The memo says that ISS generally supported them, while Glass Lewis usually opposed them. It says that as of July 5, 2023, ISS supported 80% of these officer exculpation proposals.  Another interesting tidbit is that 38 of the 47 proposals that ISS recommended against passed anyway.  The memo didn’t provide any hard data on Glass Lewis’s recommendations, but since Glass Lewis’s superpower appears to be opacity, that’s not a huge surprise.

John Jenkins